title: Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
abstract: Two epithelial tumor cell lines were established from biopsy specimens of nasopharyngeal carcinomas (NPC). The specimens were taken from poorly differentiated squamous cell carcinomas of the nasopharynx. The tissues were prepared for cell culture and eventually two continuous epithelial cell lines were obtained and designated HONE-1 and HNE-1. Light and electron microscopic examination of these two cell lines demonstrated cells with an epithelial morphology including the presence of desmosomes. The HNE-1 cell line has been passaged more than 100 times and the HONE-1 cell line has been passaged more than 90 times. It was found that early-passage uncloned HNE-1 cells (passage 23) could be superinfected with the B95-8 and NPC-EBV isolates as demonstrated by the induction of Epstein-Barr virus (EBV)-specific early antigen(s) in a small percentage of the cells; HONE-1 cells could also be superinfected with EBV. Southern blot analysis detected EBV DNA in samples from uncloned HNE-1 cells at passages 12, 17, 21, 27, and 35. However, by passage 45, EBV DNA could no longer be detected in HNE-1 cells by Southern blot analysis. The EBV genome was detected in parental HONE-1 cells at subculture 9 and in clone 40 cells up to passage 40 thus far. When HNE-1 cells were examined for the expression of the EBV-encoded nuclear antigen (EBNA) at passage 12, only about 10% of the cells were found to be positive. The percentage of EBNA-positive HNE-1 cells decreased as the cells were passaged. A similar loss of EBNA was observed in uncloned HONE-1 cells, but not in HONE-1 clone 40 cells. In clone 40, which has been passaged 40 times thus far, 85-90% of the cells are still EBNA-positive. The data suggest that EBV genome-positive HNE-1 and HONE-1 cells were lost as the cells were cultivated in vitro and that cloning the cells at an early passage level may be critical in maintaining EBV genome-positive epithelial NPC cells. These EBV genome-positive epithelial NPC cell lines will be useful for studying the association of EBV and NPC.
authors.affiliation: Department of Medical Microbiology and Immunology, Ohio State University Medical Center, Columbus 43210.
authors.forename: R
authors.initials: R
authors.lastname: Glaser
authors.forename: H Y
authors.initials: HY
authors.lastname: Zhang
authors.forename: K T
authors.initials: KT
authors.lastname: Yao
authors.forename: H C
authors.initials: HC
authors.lastname: Zhu
authors.forename: F X
authors.initials: FX
authors.lastname: Wang
authors.forename: G Y
authors.initials: GY
authors.lastname: Li
authors.forename: D S
authors.initials: DS
authors.lastname: Wen
authors.forename: Y P
authors.initials: YP
authors.lastname: Li
mesh_terms: D000956:Antigens, Viral / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000382:microbiology* / Q000473:pathology / Q000648:ultrastructure; D002460:Cell Line; D046508:Culture Techniques / Q000379:methods; D004848:Epithelium / Q000382:microbiology / Q000648:ultrastructure; D019309:Epstein-Barr Virus Nuclear Antigens; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000302:isolation & purification* / Q000648:ultrastructure; D006801:Humans; D008854:Microscopy, Electron; D009303:Nasopharyngeal Neoplasms / Q000382:microbiology* / Q000473:pathology / Q000648:ultrastructure
chemical_list: D000956:Antigens, Viral; D019309:Epstein-Barr Virus Nuclear Antigens